Research & Development
US FDA extends shelf life of J&J's COVID-19 vaccine to six months
29 July 2021 -

The US Food & Drug Administration (FDA) has extended the shelf life for US pharmaceutical company Johnson & Johnson's (NYSE:JNJ) single-shot COVID-19 vaccine to six months from four-and-a-half months, Reuters news agency reported on Thursday.

According to J&J, the FDA's decision is based on data from ongoing studies which show the vaccine is stable at six months when refrigerated at two to eight degrees Celsius.

The FDA stated in a letter to J&J that the extension was also applicable to batches that might have expired prior to the issuance of the letter, provided they were stored at the recommended temperature.



Related Headlines